Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia. Br J Cancer. 1975 Aug; 32(2):199-207.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.